Sign in
4

Changes in Ownership

Ultragenyx Pharmaceutical Inc. Filed Acc 0001209191-23-000276

President & CEO sold 19,582 shares at $45.57 ($892,352)

From the SEC's structured data for this filing

Trades in this filing

KAKKIS EMIL D · President & CEO

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2022-12-30 Sale : show line 1 in the form −19,582 $45.57 $892,352 541,108 D
Open-market sales · 19,582 sh · avg $45.57 · $892,352
Loading xslF345X03/doc4.xml…